I only just saw your "great analysis" @vic_wattle. Thanks for sharing.
I also think there is considerable upside to your valuation. Given the CAGR over the last 5 years of 31%, and the long runway of potential growth in North America and ROW, I think the actual CAGR will be higher than your conservative 10% CAGR. However, it's good to be conservative and then be pleasantly surprised with actual results than the other way around. Either way, the future does look bright and the present shareprice looks cheap for the growth on offer.
The other things I like about Mader are:
- Their very high profitability with ROIC at >30%. This indicates they are in a very strong competitive position.
- The fact that they are able to reinvest half of their profits into the business at these very high rates of return. This underpins strong future growth.
- Forums
- ASX - By Stock
- MAD
- Ann: Quarterly Operational Update - Q1 FY22
Ann: Quarterly Operational Update - Q1 FY22, page-35
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAD (ASX) to my watchlist
|
|||||
Last
$6.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.234B |
Open | High | Low | Value | Volume |
$6.20 | $6.30 | $6.13 | $217.1K | 35.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1843 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.17 | 190 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1843 | 6.120 |
1 | 227 | 6.110 |
7 | 6101 | 6.100 |
1 | 227 | 6.090 |
1 | 5000 | 6.070 |
Price($) | Vol. | No. |
---|---|---|
6.170 | 190 | 1 |
6.180 | 1287 | 2 |
6.190 | 227 | 1 |
6.200 | 977 | 2 |
6.290 | 314 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
MAD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online